COVID-19-Associated Hyperactive Intensive Care Unit Delirium With Proposed Pathophysiology and Treatment: A Case Report.
作者信息
Sher Yelizaveta, Rabkin Beatrice, Maldonado José R, Mohabir Paul
机构信息
Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, Stanford, CA.
Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, Stanford, CA.
出版信息
Psychosomatics. 2020 Sep-Oct;61(5):544-550. doi: 10.1016/j.psym.2020.05.007. Epub 2020 May 19.
Abstract
摘要
相似文献
1
COVID-19-Associated Hyperactive Intensive Care Unit Delirium With Proposed Pathophysiology and Treatment: A Case Report.
Psychosomatics. 2020 Sep-Oct;61(5):544-550. doi: 10.1016/j.psym.2020.05.007. Epub 2020 May 19.
2
Neurocovid: Pharmacological Recommendations for Delirium Associated With COVID-19.
Psychosomatics. 2020 Nov-Dec;61(6):585-596. doi: 10.1016/j.psym.2020.05.013. Epub 2020 May 21.
3
Does prolonged propofol sedation of mechanically ventilated COVID-19 patients contribute to critical illness myopathy?
Br J Anaesth. 2020 Sep;125(3):e334-e336. doi: 10.1016/j.bja.2020.05.056. Epub 2020 Jun 10.
4
Melatonin, Ramelteon, Suvorexant, and Dexmedetomidine to Promote Sleep and Prevent Delirium in Critically Ill Patients: A Narrative Review With Practical Applications.
Crit Care Nurs Q. 2020 Apr/Jun;43(2):232-250. doi: 10.1097/CNQ.0000000000000304.
5
Sedation for critically ill patients with COVID-19: Which specificities? One size does not fit all.
Anaesth Crit Care Pain Med. 2020 Jun;39(3):341-343. doi: 10.1016/j.accpm.2020.04.010. Epub 2020 Apr 29.
6
Neuroleptic malignant syndrome in a COVID-19 patient.
Brain Behav Immun. 2020 Aug;88:28-29. doi: 10.1016/j.bbi.2020.05.042. Epub 2020 May 18.
7
Valproic Acid for the Management of Agitation and Delirium in the Intensive Care Setting: A Retrospective Analysis.
Clin Ther. 2020 Apr;42(4):e65-e73. doi: 10.1016/j.clinthera.2020.02.007. Epub 2020 Apr 6.
8
Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial.
Crit Care. 2009;13(3):R75. doi: 10.1186/cc7890. Epub 2009 May 19.
9
Command Suicidal Hallucination as Initial Presentation of Coronavirus Disease 2019 (COVID-19): A Case Report.
Psychosomatics. 2020 Sep-Oct;61(5):561-564. doi: 10.1016/j.psym.2020.05.022. Epub 2020 May 30.
10
Circadian rhythm sleep-wake disorders and the COVID-19 pandemic.
J Clin Sleep Med. 2020 Aug 15;16(8):1423. doi: 10.5664/jcsm.8540.
引用本文的文献
1
Efficacy and safety of guanfacine in hospitalized patients with delirium: A scoping review.
Crit Care Resusc. 2024 Nov 24;26(4):286-294. doi: 10.1016/j.ccrj.2024.08.009. eCollection 2024 Dec.
2
Thrifty effect of subanesthetic-dose S-ketamine on postoperative opioids and its safety and analgesic effectiveness: A prospective, triple-blind, randomized controlled, polycentric clinical trial.
Ibrain. 2023 May 15;9(2):171-182. doi: 10.1002/ibra.12104. eCollection 2023 Summer.
3
Scientific rationale for the use of α2A-adrenoceptor agonists in treating neuroinflammatory cognitive disorders.
Mol Psychiatry. 2023 Nov;28(11):4540-4552. doi: 10.1038/s41380-023-02057-4. Epub 2023 Apr 7.
4
Consensus of the Liaison-Psychiatry Committee of the Colombian Psychiatric Association on the diagnosis and treatment of delirium in the context of the COVID-19 pandemic.
Rev Colomb Psiquiatr (Engl Ed). 2022 Jul-Sep;51(3):245-255. doi: 10.1016/j.rcpeng.2020.11.008. Epub 2022 Sep 1.
5
Demographic Features, Physical Examination Findings, and Medication Use in Hospitalized, Delirious Patients With and Without COVID-19 Infection: A Retrospective Study.
J Acad Consult Liaison Psychiatry. 2023 Jan-Feb;64(1):35-44. doi: 10.1016/j.jaclp.2022.07.010. Epub 2022 Aug 8.
6
Therapeutic Approaches to the Neurologic Manifestations of COVID-19.
Neurotherapeutics. 2022 Sep;19(5):1435-1466. doi: 10.1007/s13311-022-01267-y. Epub 2022 Jul 21.
7
On Patterns of Neuropsychiatric Symptoms in Patients With COVID-19: A Systematic Review of Case Reports.
Cureus. 2022 May 15;14(5):e25004. doi: 10.7759/cureus.25004. eCollection 2022 May.
8
Hope and Resilience Related to Fear of COVID-19 in Young People.
Int J Environ Res Public Health. 2022 Apr 20;19(9):5004. doi: 10.3390/ijerph19095004.
9
Pharmacological Treatment of Acute Psychiatric Symptoms in COVID-19 Patients: A Systematic Review and a Case Series.
Int J Environ Res Public Health. 2022 Apr 20;19(9):4978. doi: 10.3390/ijerph19094978.
10
Risk factors for delirium among SARS-CoV-2 positive veterans.
Psychiatry Res. 2022 Mar;309:114375. doi: 10.1016/j.psychres.2021.114375. Epub 2021 Dec 30.
本文引用的文献
1
Neurologic Features in Severe SARS-CoV-2 Infection.
N Engl J Med. 2020 Jun 4;382(23):2268-2270. doi: 10.1056/NEJMc2008597. Epub 2020 Apr 15.
2
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19.
J Infect. 2020 Jun;80(6):607-613. doi: 10.1016/j.jinf.2020.03.037. Epub 2020 Apr 10.
3
Clinical Characteristics and Outcomes of Older Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: A Single-Centered, Retrospective Study.
J Gerontol A Biol Sci Med Sci. 2020 Sep 16;75(9):1788-1795. doi: 10.1093/gerona/glaa089.
4
Collaborative Delirium Prevention in the Age of COVID-19.
J Am Geriatr Soc. 2020 May;68(5):947-949. doi: 10.1111/jgs.16480.
5
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.
JAMA Neurol. 2020 Jun 1;77(6):683-690. doi: 10.1001/jamaneurol.2020.1127.
6
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations.
Lancet Respir Med. 2020 May;8(5):506-517. doi: 10.1016/S2213-2600(20)30161-2. Epub 2020 Apr 6.
7
Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment.
Circulation. 2020 Jun 16;141(24):e906-e907. doi: 10.1161/CIRCULATIONAHA.120.047521. Epub 2020 Apr 8.
8
A first case of meningitis/encephalitis associated with SARS-Coronavirus-2.
Int J Infect Dis. 2020 May;94:55-58. doi: 10.1016/j.ijid.2020.03.062. Epub 2020 Apr 3.
9
Nervous system involvement after infection with COVID-19 and other coronaviruses.
Brain Behav Immun. 2020 Jul;87:18-22. doi: 10.1016/j.bbi.2020.03.031. Epub 2020 Mar 30.
10
COVID-19: Melatonin as a potential adjuvant treatment.
Life Sci. 2020 Jun 1;250:117583. doi: 10.1016/j.lfs.2020.117583. Epub 2020 Mar 23.
Zotero 插件